Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The economics of febrile neutropenia: implications for the use of colony-stimulating factors.
European journal of cancer (Oxford, England : 1990)·1999
Melatonin for the masses. Antiaging entrepreneurs peddle therapies that promise to cheat the clock.
Hospitals & health networks·1998
Outcome states of colorectal cancer: identification and description using patient focus groups.
The American journal of gastroenterology·1998
Nurses' aid. Labor groups look to nursing to boost their dwindling ranks, promising tough tactics.
Hospitals & health networks·1998
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·1998
Sizing up the sickest.
Hospitals & health networks·1998
Bridging the divide between health economics and outcomes research and biomedical investment: reflections from a health economist working in venture capital.
Journal of comparative effectiveness research·2026
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026